Epidemiology, Screening, and Prevention of Bladder Cancer
The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
CONTEXT Bladder cancer (BC) represents a significant health problem due to the potential morbidity and mortality associated with disease burden, which has remained largely unaltered over time. OBJECTIVE To provide an expert collaborative review and describe the incidence, prevalence, and mortality of BC and to evaluate current evidence for BC screening and prevention. EVIDENCE ACQUISITION Data on the estimated incidence and mortality of BC for 2020 in 185 countries were derived from the International Agency for Research on Cancer GLOBOCAN database. A review of English-language articles published over the past 5 yr was conducted using PubMed/MEDLINE to identify risk factors in addition to contemporary evidence on BC screening and prevention. EVIDENCE SYNTHESIS BC is the tenth most common cancer worldwide, with 573 278 cases in 2020. BC incidence is approximately fourfold higher in men than women. Tobacco smoking remains the principal risk factor, accounting for approximately 50% of cases. There is insufficient evidence to recommend routine BC screening. However, targeted screening of high-risk individuals (defined according to smoking history or occupational exposure) may reduce BC mortality and should be the focus of prospective randomized trials. In terms of disease prevention, smoking cessation represents the most important intervention, followed by a reduction in exposure to occupational and environmental carcinogens. CONCLUSIONS BC confers a significant disease burden. An understanding of BC epidemiology and risk factors provides an optimal foundation for disease prevention and the care of affected patients. PATIENT SUMMARY Bladder cancer is the tenth most common cancer worldwide and is approximately four times more common among men than among women. The main risk factors are tobacco smoking, followed by exposure to carcinogens in the workplace or the environment. Routine screening is not currently recommended, but may be beneficial in individuals at high risk, such as heavy smokers. Primary prevention is extremely important, and smoking cessation represents the most important action for reducing bladder cancer cases and deaths.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
Antoni, S., Ferlay, J., Soerjomataram, I., Znaor, A., Jemal, A., & Bray, F. (2017) · European Urology · doi:10.1016/j.eururo.2016.06.010 · Cited by 2,514
Familial Risk and Heritability of Cancer Among Twins in Nordic Countries
Mucci, L. A., Hjelmborg, J. B., Harris, J. R., Czene, K., Havelick, D. J., Scheike, T., Graff, R. E., Holst, K., Möller, S., Unger, R. H., et al. (2016) · JAMA · doi:10.1001/jama.2015.17703 · Cited by 938
Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
Damrauer, J. S., Hoadley, K. A., Chism, D. D., Fan, C., Tiganelli, C. J., Wobker, S. E., Yeh, J. J., Milowsky, M. I., Iyer, G., Parker, J. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318376111 · Cited by 877
Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018
Cumberbatch, M. G. K., Jubber, I., Black, P. C., Esperto, F., Figueroa, J. D., Kamat, A. M., Kiemeney, L., Lotan, Y., Pang, K., Silverman, D. T., et al. (2018) · European Urology · doi:10.1016/j.eururo.2018.09.001 · Cited by 820
Self-citationBell, D. A., Taylor, J. A., Paulson, D. F., Robertson, C. N., Mohler, J. L., & Lucier, G. W. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.14.1159 · Cited by 697
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
Dobruch, J., Daneshmand, S., Fisch, M., Lotan, Y., Noon, A. P., Resnick, M. J., Shariat, S. F., Zlotta, A. R., & Boorjian, S. A. (2016) · European Urology · doi:10.1016/j.eururo.2015.08.037 · Cited by 673
Self-citationGarcía-Closas, M., Malats, N., Silverman, D., Dosemeci, M., Kogevinas, M., Hein, D. W., Tardón, A., Serra, C., Carrato, A., García-Closas, R., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67137-1 · Cited by 627
Rothman, N., Garcia-Closas, M., Chatterjee, N., Malats, N., Wu, X., Figueroa, J. D., Real, F. X., Van Den Berg, D., Matullo, G., Baris, D., et al. (2010) · Nature Genetics · doi:10.1038/ng.687 · Cited by 481
Cumberbatch, M. G., Rota, M., Catto, J. W. F., & La Vecchia, C. (2016) · European Urology · doi:10.1016/j.eururo.2015.06.042 · Cited by 451
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer
Kiemeney, L. A., Thorlacius, S., Sulem, P., Geller, F., Aben, K. K. H., Stacey, S. N., Gudmundsson, J., Jakobsdottir, M., Bergthorsson, J. T., Sigurdsson, A., et al. (2008) · Nature Genetics · doi:10.1038/ng.229 · Cited by 410
Picetti, R., Deeney, M., Pastorino, S., Miller, M. R., Shah, A., Leon, D. A., Dangour, A. D., & Green, R. (2022) · Environmental Research · doi:10.1016/j.envres.2022.112988 · Cited by 397
Daniels, R. D., Kubale, T. L., Yiin, J. H., Dahm, M. M., Hales, T. R., Baris, D., Zahm, S. H., Beaumont, J. J., Waters, K. M., & Pinkerton, L. E. (2014) · Occupational and Environmental Medicine · doi:10.1136/oemed-2013-101662 · Cited by 334
Sex and racial differences in bladder cancer presentation and mortality in the US
Scosyrev, E., Noyes, K., Feng, C., & Messing, E. (2009) · Cancer · doi:10.1002/cncr.23986 · Cited by 308
Wong, M. C. S., Fung, F. D. H., Leung, C., Cheung, W. W. L., Goggins, W. B., & Ng, C. F. (2018) · Scientific Reports · doi:10.1038/s41598-018-19199-z · Cited by 308
Risks of Less Common Cancers in Proven Mutation Carriers With Lynch Syndrome
Engel, C., Loeffler, M., Steinke, V., Rahner, N., Holinski-Feder, E., Dietmaier, W., Schackert, H. K., Goergens, H., von Knebel Doeberitz, M., Goecke, T. O., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.2278 · Cited by 306
Wu, X., Ye, Y., Kiemeney, L. A., Sulem, P., Rafnar, T., Matullo, G., Seminara, D., Yoshida, T., Saeki, N., Andrew, A. S., et al. (2009) · Nature Genetics · doi:10.1038/ng.421 · Cited by 287
Cancer, Heart Disease, and Diabetes in Workers Exposed to 2,3,7,8-Tetrachlorodibenzo-p-dioxin
Steenland, K., Piacitelli, L., Deddens, J., Fingerhut, M., & Chang, L. I. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.9.779 · Cited by 284
Occupation and cancer in Britain
Rushton, L., Bagga, S., Bevan, R., Brown, T. P., Cherrie, J. W., Holmes, P., Fortunato, L., Slack, R., Van Tongeren, M., Young, C., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605637 · Cited by 265
Teoh, J. Y.-C., Huang, J., Ko, W. Y.-K., Lok, V., Choi, P., Ng, C.-F., Sengupta, S., Mostafid, H., Kamat, A. M., Black, P. C., et al. (2020) · European Urology · doi:10.1016/j.eururo.2020.09.006 · Cited by 257
Self-citationElectronic-cigarette smoke induces lung adenocarcinoma and bladder urothelial hyperplasia in mice
Tang, M.-S., Wu, X.-R., Lee, H.-W., Xia, Y., Deng, F.-M., Moreira, A. L., Chen, L.-C., Huang, W. C., & Lepor, H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911321116 · Cited by 243
Cumberbatch, M. G. K., Cox, A., Teare, D., & Catto, J. W. F. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.3209 · Cited by 242
Costet, N., Villanueva, C. M., Jaakkola, J. J. K., Kogevinas, M., Cantor, K. P., King, W. D., Lynch, C. F., Nieuwenhuijsen, M. J., & Cordier, S. (2011) · Occupational and Environmental Medicine · doi:10.1136/oem.2010.062703 · Cited by 231
van Osch, F. H., Jochems, S. H., van Schooten, F.-J., Bryan, R. T., & Zeegers, M. P. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw044 · Cited by 213
Tang, H., Dai, Q., Shi, W., Zhai, S., Song, Y., & Han, J. (2017) · Diabetologia · doi:10.1007/s00125-017-4370-8 · Cited by 206
Lower, G. M., Nilsson, T., Nelson, C. E., Wolf, H., Gamsky, T. E., & Bryan, G. T. (1979) · Environmental Health Perspectives · doi:10.1289/ehp.792971 · Cited by 201
van der Post, R. S., Kiemeney, L. A., Ligtenberg, M. J. L., Witjes, J. A., Hulsbergen-van de Kaa, C. A., Bodmer, D., Schaap, L., Kets, C. M., van Krieken, J. H. J. M., & Hoogerbrugge, N. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2010.076992 · Cited by 197
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer
Kiemeney, L. A., Sulem, P., Besenbacher, S., Vermeulen, S. H., Sigurdsson, A., Thorleifsson, G., Gudbjartsson, D. F., Stacey, S. N., Gudmundsson, J., Zanon, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.558 · Cited by 188
Meta-analysis of studies on individual consumption of chlorinated drinking water and bladder cancer
Villanueva, C. M., Fernández, F., Malats, N., Grimalt, J. O., & Kogevinas, M. (2003) · Journal of Epidemiology and Community Health · doi:10.1136/jech.57.3.166 · Cited by 180
Stec, A. A., Dickens, K. E., Salden, M., Hewitt, F. E., Watts, D. P., Houldsworth, P. E., & Martin, F. L. (2018) · Scientific Reports · doi:10.1038/s41598-018-20616-6 · Cited by 179
Trihalomethanes in Drinking Water and Bladder Cancer Burden in the European Union
Evlampidou, I., Font-Ribera, L., Rojas-Rueda, D., Gracia-Lavedan, E., Costet, N., Pearce, N., Vineis, P., Jaakkola, J. J. K., Delloye, F., Makris, K. C., et al. (2020) · Environmental Health Perspectives · doi:10.1289/ehp4495 · Cited by 178
Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes
Catto, J. W. F., Downing, A., Mason, S., Wright, P., Absolom, K., Bottomley, S., Hounsome, L., Hussain, S., Varughese, M., Raw, C., et al. (2021) · European Urology · doi:10.1016/j.eururo.2021.01.032 · Cited by 172
Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic
Baris, D., Waddell, R. D., Freeman, L. E. B., Schwenn, M. R., Colt, J. S., Ayotte, J. D., Ward, M. H., Nuckols, J. R., Schned, A. R., Jackson, B. P., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw099 · Cited by 168
Pioglitazone and bladder cancer risk: a systematic review and meta‐analysis
Tang, H., Shi, W., Fu, S., Wang, T., Zhai, S., Song, Y., & Han, J. (2018) · Cancer Medicine · doi:10.1002/cam4.1354 · Cited by 154
Stern, M. C., Lin, J. M., Figueroa, J. D., Kelsey, K. T., Kiltie, A. E., Yuan, J., Matullo, G., Fletcher, T., Benhamou, S., Taylor, J. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1091 · Cited by 152
Cancer Susceptibility Mutations in Patients With Urothelial Malignancies
Carlo, M. I., Ravichandran, V., Srinavasan, P., Bandlamudi, C., Kemel, Y. M., Ceyhan‐Birsoy, O., Mukherjee, S., Mandelker, D. L., Chaim, J. L., Knežević, A., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.01395 · Cited by 149
Trends in Inhalation Exposure—A Review of the Data in the Published Scientific Literature
Creely, K. S., Cowie, H. A., van Tongeren, M., Kromhout, H., Tickner, J., & Cherrie, J. W. (2007) · The Annals of Occupational Hygiene · doi:10.1093/annhyg/mem050 · Cited by 139
Bjurlin, M. A., Matulewicz, R. S., Roberts, T. R., Dearing, B. A., Schatz, D., Sherman, S. E., Gordon, T., & Shahawy, O. E. (2020) · European Urology Oncology · doi:10.1016/j.euo.2020.02.004 · Cited by 121
Keir, J., Akhtar, U. S., Matschke, D., Kirkham, T. L., Chan, H. M., Ayotte, P., White, P. A., & Blais, J. M. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.7b02850 · Cited by 115
Skeldon, S., Semotiuk, K., Aronson, M. D., Holter, S., Gallinger, S., Pollett, A. F., Kuk, C., van Rhijn, B., Boström, P. J., Cohen, Z., et al. (2012) · European Urology · doi:10.1016/j.eururo.2012.07.047 · Cited by 112
Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma
Nassar, A. H., Alaiwi, S. A., AlDubayan, S. H., Moore, N., Mouw, K. W., Kwiatkowski, D. J., Choueiri, T. K., Curran, C. R., Berchuck, J. E., Harshman, L. C., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0720-x · Cited by 106
Impact of a Bladder Cancer Diagnosis on Smoking Behavior
Bassett, J. C., Gore, J. L., Chi, A. C., Kwan, L. C., McCarthy, W. J., Chamie, K., & Saigal, C. S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.6518 · Cited by 103
Salem, H. K., & Mahfouz, S. (2011) · Urology · doi:10.1016/j.urology.2011.08.072 · Cited by 99
Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
Filipova, E., Uzunova, K., Kalinov, K., & Vekov, T. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0273-4 · Cited by 87
Koti, M., Ingersoll, M. A., Gupta, S., Lam, C. M., Li, X., Kamat, A. M., Black, P. C., & Siemens, D. R. (2020) · European Urology Oncology · doi:10.1016/j.euo.2020.08.013 · Cited by 87
Self-citationBjurlin, M. A., Goble, S. M., & Hollowell, C. M. P. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.06.140 · Cited by 86
Dicembrini, I., Nreu, B., Mannucci, E., & Monami, M. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13745 · Cited by 85
Biomarker Risk Assessment and Bladder Cancer Detection in a Cohort Exposed to Benzidine
Hemstreet, G. P., Yin, S., Ma, Z., Bonner, R. B., Bi, W., Rao, J., Zang, M., Zheng, Q., Bane, B. L., Asal, N. R., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.6.427 · Cited by 78
Diabetes mellitus and the risk of bladder cancer: A PRISMA-compliant meta-analysis of cohort studies
Xu, Y., Huo, R., Chen, X., & Yu, X. (2017) · Medicine · doi:10.1097/md.0000000000008588 · Cited by 76
Witlox, W. J. A., van Osch, F., Brinkman, M. T., Jochems, S. H. J., Goossens, M. E., Weiderpass, E., White, E., van den Brandt, P. A., Giles, G. G., Milne, R. L., et al. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-01907-8 · Cited by 74
Brief Smoking Cessation Intervention: A Prospective Trial in the Urology Setting
Bjurlin, M. A., Cohn, M. R., Kim, D. Y., Freeman, V. L., Lombardo, L. M., Hurley, S. D., & Hollowell, C. M. P. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.11.075 · Cited by 71
the UroScreen Study Group, Pesch, B., Taeger, D., Johnen, G., Gawrych, K., Bonberg, N., Schwentner, C., Wellhäußer, H., Kluckert, M., Leng, G., et al. (2013) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-013-0916-3 · Cited by 71
Self-citationUhlig, A., Strauß, A., Hosseini, A. S. A., Lotz, J., Trojan, L., Schmid, M., & Uhlig, J. (2017) · European Urology Focus · doi:10.1016/j.euf.2017.08.007 · Cited by 66
Zhang, Y., Birmann, B. M., Han, J., Giovannucci, E. L., Speizer, F. E., Stampfer, M. J., ROSNER, B. A., & Schernhammer, E. S. (2020) · BMJ · doi:10.1136/bmj.m2942 · Cited by 63
Agent Orange exposure and risk of death in Korean Vietnam veterans: Korean Veterans Health Study
Yi, S., Ryu, S. Y., Ohrr, H., & Hong, J. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu183 · Cited by 61
Agent Orange exposure and cancer incidence in Korean Vietnam veterans: A prospective cohort study
Yi, S., & Ohrr, H. (2014) · Cancer · doi:10.1002/cncr.28961 · Cited by 57
Racial variation in the quality of surgical care for bladder cancer
Barocas, D. A., Alvarez, J., Koyama, T., Anderson, C. B., Gray, D. T., Fowke, J. H., You, C., Chang, S. S., Cookson, M. S., Smith, J. A. J., et al. (2013) · Cancer · doi:10.1002/cncr.28520 · Cited by 55
Pedersen, M., Stafoggia, M., Weinmayr, G., Andersen, Z. J., Galassi, C., Sommar, J. N., Forsberg, B., Olsson, D., Oftedal, B., Krog, N. H., et al. (2016) · European Urology Focus · doi:10.1016/j.euf.2016.11.008 · Cited by 51
Cancer risks in recipients of renal transplants: a meta-analysis of cohort studies
Wang, Y., Lan, G., Peng, F., & Xie, X. (2017) · Oncotarget · doi:10.18632/oncotarget.23841 · Cited by 48
Knowledge of the harms of tobacco use among patients with bladder cancer
Bassett, J. C., Gore, J. L., Kwan, L. C., Ritch, C. R., Barocas, D. A., Penson, D. F., McCarthy, W. J., & Saigal, C. S. (2014) · Cancer · doi:10.1002/cncr.28915 · Cited by 46
Dietary patterns and risk of bladder cancer: a systematic review and meta-analysis
Dianatinasab, M., Forozani, E., Akbari, A., Azmi, N., Bastam, D., Fararouei, M., Wesselius, A., & Zeegres, M. P. (2022) · BMC Public Health · doi:10.1186/s12889-022-12516-2 · Cited by 44
Al-Zalabani, A. H., Wesselius, A., Yu, E. Y.-W., van den Brandt, P. A., Grant, E. J., White, E., Skeie, G., Liedberg, F., Weiderpass, E., & Zeegers, M. P. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.03.020 · Cited by 44
Common germline-somatic variant interactions in advanced urothelial cancer
Vosoughi, A., Zhang, T., Shohdy, K. S., Vlachostergios, P. J., Wilkes, D. C., Bhinder, B., Tagawa, S. T., Nanus, D. M., Molina, A. M., Beltran, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19971-8 · Cited by 43
Rink, M., Xylinas, E. N., Babjuk, M. M., et al. (2012) · European Urology · doi:10.1016/j.eururo.2012.08.057 · Cited by 42
Akhtar, S., AlShammari, A. M., & Al-Abkal, J. (2018) · World Journal of Urology · doi:10.1007/s00345-018-2206-x · Cited by 42
Yan, H., Xie, H., Ying, Y., Li, J., Wang, X., Xu, X., & Zheng, X. (2018) · Cancer Management and Research · doi:10.2147/cmar.s164840 · Cited by 39
Ripamonti, E., Azoulay, L., Abrahamowicz, M., Platt, R. W., & Suissa, S. (2018) · Diabetic Medicine · doi:10.1111/dme.13854 · Cited by 39
Mehtälä, J., Khanfir, H., Bennett, D., Ye, Y., Korhonen, P. A., & Hoti, F. J. (2018) · Diabetology International · doi:10.1007/s13340-018-0360-4 · Cited by 37
Cherrie, J. W., Hutchings, S. J., Ng, M. G., Mistry, R., Corden, C., Lamb, J., Jiménez, A. S., Shafrir, A., Sobey, M., van Tongeren, M., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.161 · Cited by 36
Goossens, M. E., Isa, F., Brinkman, M. T., Mak, D., Reulen, R. C., Wesselius, A., Benhamou, S., Bosetti, C., Bueno-de-Mesquita, B. H., Carta, A., et al. (2016) · Archives of Public Health · doi:10.1186/s13690-016-0140-1 · Cited by 35
Bladder Cancer Screening among Primary Aluminum Production Workers in Quebec
riault, G. P. T., Tremblay, C. G., & Armstrong, B. (1990) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-199009000-00021 · Cited by 32
Lao, Y., Li, X., He, L., Guan, X., Li, R., Wang, Y., Li, Y., Wang, Y., Li, X., Liu, S., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.696676 · Cited by 32
Adil, M., Khan, R. A., Ghosh, P., Venkata, S. K., Kandhare, A. D., & Sharma, M. (2017) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2017.08.002 · Cited by 31
Yu, E. Y.-W., Dai, Y., Wesselius, A., van Osch, F., Brinkman, M. T., van den Brandt, P. A., Grant, E. J., White, E., Weiderpass, E., Gunter, M. J., et al. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-019-00597-0 · Cited by 31
Dianatinasab, M., Wesselius, A., de Loeij, T., Salehi‐Abargouei, A., Yu, E. Y.-W., Fararouei, M., Brinkman, M. T., van den Brandt, P. A., White, E., Weiderpass, E., et al. (2021) · European Journal of Epidemiology · doi:10.1007/s10654-021-00762-4 · Cited by 30
Proximity to Oil Refineries and Risk of Cancer: A Population-Based Analysis
Williams, S. B., Shan, Y., Jazzar, U., Kerr, P. S., Okereke, I. C., Klimberg, V. S., Tyler, D. S., Putluri, N., López, D. S., Prochaska, J. D., et al. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa088 · Cited by 26
Self-citationPemov, A., Wegman-Ostrosky, T., Kim, J., Koutros, S., Douthitt, B., Jones, K., Zhu, B., Baris, D., Schwenn, M. R., Johnson, A. T., et al. (2021) · JCO Precision Oncology · doi:10.1200/po.21.00115 · Cited by 23
Pan-cancer immunogenomic analyses reveal sex disparity in the efficacy of cancer immunotherapy
Wang, P., Song, H., Zhang, Q., & Yan, C. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2019.12.008 · Cited by 22
Prevalence and Correlates of Successful Smoking Cessation in Bladder Cancer Survivors
Bassett, J. C., Matulewicz, R. S., Kwan, L. C., McCarthy, W. J., Gore, J. L., & Saigal, C. S. (2021) · Urology · doi:10.1016/j.urology.2020.12.033 · Cited by 22
Dianatinasab, M., Wesselius, A., Salehi‐Abargouei, A., Yu, E. Y.-W., Fararouei, M., Brinkman, M. T., van den Brandt, P. A., White, E., Weiderpass, E., Calvez‐Kelm, F. L., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.33970 · Cited by 22
Modeling the Complex Exposure History of Smoking in Predicting Bladder Cancer
van Osch, F., Vlaanderen, J. J., Jochems, S. H. J., Bosetti, C., Polesel, J., Porru, S., Carta, A., Golka, K., Jiang, X., Stern, M. C., et al. (2019) · Epidemiology · doi:10.1097/ede.0000000000000964 · Cited by 17
You, S., Kim, M., Widen, S. G., Yu, A., Galván, G. C., Choi-Kuaea, Y., Eyzaguirre, E. J., Dyrskjøt, L., McConkey, D. J., Choi, W., et al. (2022) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2022.04.013 · Cited by 14
Self-citationMatulewicz, R. S., Bassett, J. C., Kwan, L. C., Sherman, S. E., McCarthy, W. J., Saigal, C. S., & Gore, J. L. (2021) · Cancer · doi:10.1002/cncr.34054 · Cited by 13
Shah, A. A., Sun, Z., Eom, K. Y., Grajales, V., Pekala, K. R., Davies, B. J., Jacobs, B. L., & Sabik, L. M. (2022) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2021.12.004 · Cited by 11
van Hattum, J. W., de Ruiter, B. M., Oddens, J. R., de Reijke, T. M., Wilmink, J. W., & Molenaar, R. J. (2022) · Bladder Cancer · doi:10.3233/blc-211653 · Cited by 6
Cited by
Dyrskjøt, L., Hansel, D. E., Efstathiou, J. A., Knowles, M. A., Galsky, M. D., Teoh, J., & Theodorescu, D. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00468-9 · Cited by 544
Advances in diagnosis and treatment of bladder cancer
Lopez-Beltran, A., Cookson, M. S., Guercio, B. J., & Cheng, L. (2024) · BMJ · doi:10.1136/bmj-2023-076743 · Cited by 496
Metadata
- Authors
- Lobo, N., Afferi, L., Moschini, M., Mostafid, H., Porten, S., Psutka, S. P., Gupta, S., Smith, A. B., Williams, S. B., & Lotan, Y.
- Venue
- European Urology Oncology
- Publisher
- Elsevier BV
- Published
- 2022-12
- Volume
- 5
- Issue
- 6
- Pages
- 628-639
- ISSN
- 2588-9311 (ISSN-L)
- OpenAlex
- W4308253982
- Cited by
- 372
- References
- 85
- FWCI
- 59.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.